What is the 13F Pro Quality Score for ITGR?

13F Pro ranks Integer Holdings Corp (ITGR) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ITGR's current score at https://13fpro.ai/research/ITGR (free sign-up required for the full ranking).

Which hedge funds own the most ITGR stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of ITGR include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, Invesco Ltd.. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/ITGR as soon as new 13F filings post.

Where does 13F Pro source ITGR data?

All Integer Holdings Corp fundamentals and ownership data come directly from SEC EDGAR. Integer Holdings Corp files with the SEC under CIK 1114483. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ITGR in?

Integer Holdings Corp (ITGR) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ITGR research updated on 13F Pro?

ITGR's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Integer Holdings Corp(ITGR)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 1114483 ITGR stock profile & AI dashboard →

13F Pro Quality Score

50.2/100

Rank #1,472 of 2,879 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

60.2/100

Profitability

40.2/100

Balance Sheet

52.0/100

Earnings Quality

28.0/100

Free Cash Flow

48.5/100

Institutional Flow

39.0/100

Revenue Scale

60.8/100

Dilution Risk

51.3/100

ITGR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Integer Holdings Corp (ITGR), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ITGR at 50.2/100 on a 32-signal composite quality model, placing it at rank #1,472 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (28.0) and institutional flow (39.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Integer Holdings Corp reports quarterly revenue of $439.6M, net income of $16.5M, an operating margin of 7.2%. Top institutional holders of ITGR by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, Invesco Ltd., based on the most recent SEC filings. ITGR trades on the NYSE exchange and files with the SEC under CIK 1114483. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ITGR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Integer Holdings Corp directly from SEC EDGAR. Integer Holdings Corp's 13F Pro composite quality score has ranged between 40 and 64 since 2021, currently 50.2 — a stable long-term trajectory across 30 quarterly and live scoring snapshots.

✦

Fun facts about Integer Holdings Corp

Quirks, history, and lore behind ITGR — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. medical device company · mid-cap · listed on NYSE · headquartered in Texas.
2
The Numbers
Annual revenue in the range of $1.5 billion, with operations spanning roughly 30 countries — a global footprint that belies its under-the-radar profile.
3
The History
Traces its roots to a cardiac rhythm management supplier founded in the 1970s, eventually growing through acquisitions into a broad implantable device manufacturer.
4
The Secret
It doesn't make the flashy gadgets — it makes the components inside them: batteries, capacitors, and precision parts that other medtech giants quietly buy and build into their own branded devices.
5
The Lore
Its customers include virtually every major cardiac and neuromodulation device maker on the planet, meaning its parts may already be ticking away inside millions of patients right now.
6
The Giveaway
Its ticker is a math word, its name is a math word, but its specialty is the implantable medical components — batteries, leads, and enclosures — powering pacemakers and neurostimulators worldwide.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$439.6M

Net Income

Q1 2026

$16.5M

Free Cash Flow

Q1 2026

$737.0K

Operating Margin

Q1 2026

7.2%

ROIC

Q1 2026

1.1%

D/E Ratio

Q1 2026

0.74

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+10.3% YoY

$1.72BFY 2024

FY21 $1.22BFY22 $1.33BFY23 $1.56BFY24 $1.72B

Net Income

+32.3% YoY

$119.9MFY 2024

FY21 $96.8MFY22 $66.4MFY23 $90.7MFY24 $119.9M

Operating Income

+27.5% YoY

$208.2MFY 2024

FY21 $135.7MFY22 $112.7MFY23 $163.3MFY24 $208.2M

EPS (Diluted)

+24.9% YoY

$3.36FY 2024

FY21 $2.91FY22 $1.99FY23 $2.69FY24 $3.36

Total Assets

+4.6% YoY

$3.08BFY 2024

FY21 $2.58BFY22 $2.79BFY23 $2.94BFY24 $3.08B

Total Debt

+4.2% YoY

$1.00BFY 2024

FY21 $843.4MFY22 $943.4MFY23 $959.9MFY24 $1.00B

Op. Cash Flow

+13.9% YoY

$205.2MFY 2024

FY21 $156.7MFY22 $116.4MFY23 $180.2MFY24 $205.2M

Metric	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Revenue	$1.72B +10.3%	$1.56B +16.9%	$1.33B +9.0%	$1.22B +13.8%	$1.07B -14.7%	$1.26B
Net Income	$119.9M +32.3%	$90.7M +36.6%	$66.4M -31.4%	$96.8M +25.3%	$77.3M -19.8%	$96.3M
Operating Income	$208.2M +27.5%	$163.3M +44.9%	$112.7M -17.0%	$135.7M +12.5%	$120.6M -23.5%	$157.6M
EPS (Diluted)	$3.36 +24.9%	$2.69 +35.2%	$1.99 -31.6%	$2.91 +24.9%	$2.33 -20.2%	$2.92
Total Assets	$3.08B +4.6%	$2.94B +5.3%	$2.79B +8.2%	$2.58B +8.9%	$2.37B +0.8%	$2.35B
Total Debt	$1.00B +4.2%	$959.9M +1.7%	$943.4M +11.9%	$843.4M +9.7%	$768.8M -9.8%	$852.3M
Operating Cash Flow	$205.2M +13.9%	$180.2M +54.8%	$116.4M -25.7%	$156.7M -13.6%	$181.3M +9.7%	$165.4M

AI Insight: ITGR Financial Trends

Integer Holdings posted weakest operating margin (7.3%) and cash generation ($25M) in two years as Q2 2026 revenue declined.

• Revenue fell to $440M in Q2 2026 from $472M in Q4 2025, marking first sequential decline in six quarters.

• Operating margin compressed to 7.3% in Q2 2026 versus 12.1% in Q4 2025; net income collapsed to $17M from $49M.

• Operating cash flow deteriorated to $25M in Q2 2026 from $55M in Q4 2025, lowest since Q2 2024.

• Debt rose to $1,252M in Q2 2026 from $1,185M in Q4 2025 as equity remained flat, increasing leverage.

⚠ Unusual $22M net loss in Q1 2025 disrupted otherwise consistent profitability; Q2 2026 weakness suggests potential structural issue.

⚠ Operating income halved from $56M in Q4 2025 to $32M in Q2 2026; margin recovery critical to restore credibility.

AI Insight: ITGR Ratio Trends

Operating margin and profitability collapsed in Q2 2026, with ROIC halving to 4.3% and net profit margin plummeting to 3.8%.

• Operating margin fell 410 bps in Q2 2026 to 7.2%, the lowest in dataset history; TTM OpMargin now 11.0%.

• Net profit margin spiked to 10.3% in Q4 2025, then crashed to 3.8% in Q2 2026, signaling earnings volatility or one-time charges.

• ROE and ROA both dropped ~60% quarter-over-quarter to 3.9% and 1.9%, respectively, in Q2 2026.

⚠ ROIC declined from 7.6% (TTM) to 4.3% (Q2 2026)—fastest deterioration in the dataset; reversal required.

⚠ Debt-to-equity rose to 0.74 in Q2 2026 from 0.68 in prior quarters, signaling leverage creep amid margin pressure.

Get alerted when ITGR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Integer Holdings Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ITGR

BlackRock, Inc.
$466.9M5,305,841 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$180.1M2,046,966 sh
Invesco Ltd.
$173.3M1,969,133 sh
MORGAN STANLEY
$135.5M1,539,283 sh
VANGUARD CAPITAL MANAGEMENT LLC
$135.3M1,537,287 sh
DIMENSIONAL FUND ADVISORS LP
$130.6M1,484,396 sh
STATE STREET CORP
$123.0M1,398,286 sh
Irenic Capital Management LP
$111.2M1,263,663 sh
ALLIANCEBERNSTEIN L.P.
$102.2M1,303,384 sh
EARNEST PARTNERS LLC
$91.6M1,041,148 sh

Fund	Value	Shares
BlackRock, Inc.	$466.9M	5,305,841
VANGUARD PORTFOLIO MANAGEMENT LLC	$180.1M	2,046,966
Invesco Ltd.	$173.3M	1,969,133
MORGAN STANLEY	$135.5M	1,539,283
VANGUARD CAPITAL MANAGEMENT LLC	$135.3M	1,537,287
DIMENSIONAL FUND ADVISORS LP	$130.6M	1,484,396
STATE STREET CORP	$123.0M	1,398,286
Irenic Capital Management LP	$111.2M	1,263,663
ALLIANCEBERNSTEIN L.P.	$102.2M	1,303,384
EARNEST PARTNERS LLC	$91.6M	1,041,148

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ITGR on your watchlist

Track score changes the day Integer Holdings Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ITGR a good stock to buy?

13F Pro's AI-powered analysis of Integer Holdings Corp (ITGR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ITGR are available on the ITGR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ITGR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ITGR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Integer Holdings Corp's investment landscape.